Dupilumab in patients with diffuse type 2 CRSwNP had beneficial changes in nasal passage microbiota but did not alter gastrointestinal microbiota.

This makes one nasal passage smaller than the other. It’s estimated that as many as 80 percent of people have a deviated septum, per the American Academy of Otolaryngology-Head and Neck Surgery.